Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Dongkook Pharmaceutical’s Centellian24 Expands U.S. Retail Presence at Costco, Ulta Beauty and Nordstrom

Dongkook Pharmaceutical said on Aug. 10 that its derma-cosmetic brand Centellian24 has expanded its U.S. retail presence through Costco, Ulta Beauty and Nordstrom, accelerating its push into the North American skincare market.The expansion marks a shift in Centellian24’s U.S. strategy from primarily

Dongkook Pharmaceutical announced on August 10 that its Centellian24 derma-cosmetic brand has expanded its presence in U.S. retail stores through Costco, Ulta Beauty, and Nordstrom. This strategy shift moves away from primarily online channels like Amazon and TikTok Shop, aiming to reach mainstream American consumers. Since July, Centellian24 has sold its 100-milliliter Madeca Cream Time Reverse at around 200 Costco locations nationwide, catering to the store's bulk-focused retail model.

The brand is also increasing its reach at Ulta Beauty, adding products such as PDRN, Madeca Matcha, Mela Capture, and the Madeca Prime Max beauty device. With an expanded selection now available at approximately 760 Ulta Beauty stores across the U.S., Centellian24 products can now be found at around 89 Nordstrom locations and online.

This move follows strong e-commerce sales, with Centellian24's Amazon Prime Day performance in June boosting the brand's profile. Centellian24, developed by Dongkook Pharmaceutical, combines the company's pharmaceutical and dermatological research with cosmetics, focusing on Centella asiatica-derived ingredients. The brand has sold over 97 million units of its flagship Madeca Cream globally, and its expansion into major U.S. retail chains like Costco, Ulta Beauty, and Nordstrom provides greater access to mainstream beauty shoppers, enhancing Centellian24's U.S. market position.

Written by urgent.news from Korea IT Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at koreaittimes.com →

More in Health & Medicine

More from Tuesday 11 August →